Growth and differentiation of C2 myogenic cells are dependent on serum response factor

Molecular and Cellular Biology

Volumn 16, Issue 11, 1996, Pages 6065-6074

  Soulez, Marielle ^a   Rouviere, Cécile Gauthier ^b   Chafey, Philippe ^a   Hentzen, Danièle ^a   Vandromme, Marie ^b   Lautredou, Nicole ^b   Lamb, Ned ^b   Kahn, Axel ^a,c   Tuil, David ^a  

^a INSERM   (France)

^b Centre National de la Recherche Scientifique   (France)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CYCLIN A; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MYOGENIN; MYOSIN HEAVY CHAIN; PROTEIN; RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL GROWTH; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RNA SYNTHESIS;

ANIMALIA; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; TUMOR VIRUS;

EID: 0029851618     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.11.6065     Document Type: Article

References (65)

1. Bertagna, X. 1989. L'action antiglucocorticoïde du RU486. Ann. Endocrinol. 50:208-217.
2. Blau, H. M., C. P. Chiu, and C. Webster. 1983. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32:1171-1180.
3. Boxer, L. M., R. Prywes, R. G. Roeder, and L. Kedes. 1989. The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Mol. Cell. Biol. 9:515-522.
4. Cavigelli, M., F. Dolfi, F. Claret, and M. Karin. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:5957-5964.
5. Christy, B., and D. Nathans. 1989. Functional serum response elements upstream of the growth factor-inducible gene zif268. Mol. Cell. Biol. 9:4889-4895.
6. Concordet, J.-P., M. Salminen, J. Demignon, C. Moch, P. Maire, A. Kahn, and D. Daegelen. 1993. An opportunistic promoter sharing regulatory sequences with either a muscle-specific or a ubiquitous promoter in the human aldolase A gene. Mol. Cell. Biol. 13:9-17.
7. Dalton, S., R. Marais, J. Wynne, and R. Treisman. 1993. Isolation and characterization of SRF accessory proteins. Philos. Trans. R. Soc. Lond. B 340:325-332.
8. Dalton, S., and R. Treisman. 1992. Characterisation of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68:597-612.
9. Desdouets, C., C. Ony, G. Matesic, T. Soussi, C. Bréchot, and J. Sobczack-Thépot. 1996. ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter. FEBS Lett. 385:34-38.
10. Ernst, H., K. Walsh, C. A. Harrison, and N. Rosenthal. 1991. The myosin light chain enhancer and the skeletal actin promoter share a binding site for factors involved in muscle-specific gene expression. Mol. Cell. Biol. 11:3735-3744.
11. Gauthier-Rouviere, C., J. C. Cavadore, J. M. Blanchard, N. J. C. Lamb, and A. Fernandez. 1991. p67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period. Cell Regul. 2:575-588.
12. Gauthier-Rouviere, C., M. Vandromme, D. Tuil, N. Lautredou, M. Morris, M. Soulez, A. Kahn, A. Fernandez, and N. Lamb. 1996. Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol. Biol. Cell 7:719-729.
13. Gilgenkrantz, H., J. P. Hugnot, M. Lambert, P. Chafey, J. C. Kaplan, and A. Kahn. 1992. Positive and negative regulatory DNA elements including CCArGG box hut not MyoD1 binding sites control the cell-type specific expression of the human muscle dystrophin gene. J. Biol. Chem. 267:10823-10830.
14. Girard, F., U. Strausfeld, and N. J. C. Fernandez. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179.
15. Gouilleux, F., B. Sola, B. Couette, and H. Richard-Foy. 1991. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter. Nucleic Acids Res. 19:1563-1569.
16. Groisman, R., H. Masutani, M. P. Leibovitch, P. Robin, I. Soudant, D. Trouche, and A. Harel-Bellan. 1996. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins. J. Biol. Chem. 271:5258-5264.
17. Guo, K., J. Wang, V. Andres, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
18. Gustafson, T. A., T. Miwa, L. M. Boxer, and L. Kedes. 1988. Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac α-actin promoter. Mol. Cell. Biol. 8:4110-4119.
19. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
20. TCF. Nature (London) 354:531-534.
21. Iwaki, T., A. Iwaki, J. Tateishi, and J. E. Goldman. 1994. Sense and antisense modification of glial αB-Cristallin production results in alterations of stress fiber formation and thermoresistance. J. Cell Biol. 125:1385-1393.
22. Johansen, F. E., and R. Prywes. 1993. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol. Cell. Biol. 13:4640-4647.
23. Karin, M., and T. Hunter. 1995. Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5:747-757.
24. Keely, P. J., A. M. Fong, M. M. Zutter, and S. A. Santoro. 1995. Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense α2 integrin mRNA in mammary cells. J. Cell Sci. 108:595-607.
25. Kiess, M., R. M. Gill, and P. A. Hamel. 1995. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene 10:159-166.
26. Lamas, E., F. Zindy, J. Sobczack, P. Paterlini, J. Wang, X. Chenivesse, B. Henglein, and C. Bréchot. 1993. Cyclinc A et cancer. Med. Sci. 9:676-683.
27. Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788-794.
28. Lee, T. C., K. L. Chow, P. Fang, and R. J. Schwartz. 1991. Activation of skeletal alpha-actin gene transcription: the cooperative formation of serum response factor-binding complexes over positive cis-acting promoter serum response elements displaces a negative-acting nuclear factor enriched in replicating myoblasts and nonmyogenic cells. Mol. Cell. Biol. 11:5090-5100.
29. Leifer, D., D. Krainc, Y. T. Yu, J. McDermott, R. E. Breitbart, J. Heng, R. L. Neve, B. Kosofsky, B. Nadal-Ginard, and S. A. Lipton. 1993. MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc. Natl. Acad. Sci. USA 90:1546-1604.
30. Ludolph, D. C., and S. F. Konieczny. 1995. Transcriptional factor families: muscling in on the myogenic program. FASEB J. 9:1595-1604.
31. Martelli, F., C. Cenciarelli, G. Santarelli, B. Polikar, A. Felsani, and M. Caruso. 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 9:3579-3590.
32. Minty, A., H. Blau, and L. Kedes. 1986. Two-level regulation of cardiac actin gene transcription: muscle-specific modulating factors can accumulate before gene activation. Mol. Cell. Biol. 6:2137-2148.
33. Misra, R. P., V. M. Rivera, J. M. Wang, P. D. Fan, and M. E. Greenberg. 1991. The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts. Mol. Cell. Biol. 11: 4545-4554.
34. Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, C. M. Livingslon, and G. P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip/WAF1 and the E1A-associated p.300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451-5455.
35. Mohun, T. J., A. E. Chambers, N. Towers, and M. V. Taylor. 1991. Expression of genes encoding the transcription factor SRF during early development of Xenopus laevis: identification of a CArG box-binding activity as SRF. EMBO J. 10:933-940.
36. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic hHLH proteins. Cell 83:1125-1136.
37. Muscat, G. E. O., and L. Kedes. 1987. Multiple 5′-flanking regions of the human α-skeletal actin gene synergistically modulate muscle-specific expression. Mol. Cell. Biol. 7:4089-4099.
38. Nellen, W., and C. Lichtenstein. 1993. What makes an RNA anti-sensitive? Trends Biochem. Sci. 18:419-423.
39. Norman, C., M. Runswick, R. Pollock, and R. Treisman. 1988. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55:989-1003.
40. Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olson, J. W. Harper, and S. J. Elledge. 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
41. Passaquin, A. C., K. Bouri, L. Metzinger, G. Coupin, J. M. Warter, and P. Poindron. 1994. Differentiation of C2 skeletal muscle cells is enhanced by alpha-methylprednisolone. Int. J. Immunopathol. Pharmacol. 7:37-45.
42. Phan-Dinh-Tuy, F., D. Tuil, F. Schweighoffer, C. Pinset, A. Kahn, and A. Minty. 1988. A protein-binding site common to transcription-regulatory regions of the cardiac actin, c-fos and interleukin-2 receptor genes. Eur. J. Biochem. 173:507-515.
43. Pollock, R., and R. Treisman. 1991. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5:2327-2341.
44. Rao, S. S., C. Chu, and D. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
45. Rothhut, B., T. Dubois, D. Feliers, F. Russo-Marie, and J.-P. Oudinet. 1995. Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur. J. Biochem. 232:865-872.
46. Shore, P., and A. D. Sharrocks. 1995. The MADS-box family of transcription factors. Eur. J. Biochem. 229:1-13.
47. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024. (Comments.)
48. Soulez, M., D. Tuil, A. Kahn, and H. Gilgenkrantz. 1996. The serum response factor (SRF) is needed for muscle-specific activation of CArG boxes. Biochem. Biophys. Res Commun. 219:418-422.
49. Taylor, A., H. P. Erba, G. E. O. Muscat, and L. Kedes. 1988. Nucleotide sequence and expression of the human skeletal α-actin gene: evolution of functional regulatory domains. Genomics 3:323-336.
50. Taylor, M., R. Treisman, N. Garrett, and T. Mohun. 1989. Muscle-specific (CArG) and serum-responsive (SRE) promoter elements are functionally interchangeable in Xenopus embryos and mouse fibroblasts. Development 106:67-78.
51. Taylor, M. V. 1991. A family of muscle gene promoter element (CArG) binding activities in Xenopus embryos: CArG/SRE discrimination and distribution during myogenesis. Nucleic Acids Res. 19:2669-2675.
52. Thayer, M. J., S. J. Tapscott, R. L. Davies, W. E. Wright, A. B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58:241-248.
53. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
54. Treisman, R. 1985. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell 42:889-902.
55. Treisman, R. 1994. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:96-101.
56. Tuil, D., N. Clergue, D. Montarras, C. Pinset, A. Kahn, and F. Phan-Dinh-Tuy. 1990. CCArGG boxes, cis-elements with a dual specificity. J. Mol. Biol. 213:677-686.
57. Tuil, D., M. Soulez, D. Montarras, C. Pinset, A. Kahn, and F. Phan-Dinh-Tuy. 1993. Activation of gene expression via CArG boxes during myogenic differentiation. Exp. Cell. Res. 205:32-38.
58. 57a. Tuil, D. Unpublished data.
59. Vandromme, M., C. Gauthier Rouviere, C. Carnac, N. Lamb, and A. Fernandez. 1992. Serum response factor p67 (SRF) is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J. Cell. Biol. 118:1489-1500.
60. Waskiewicz, A. J., and J. A. Cooper. 1995. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7:798-805.
61. Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
62. Wiman, K. G. 1993. The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J. 7:841-845.
63. Wright, W. E., M. Binder, and W. Funk. 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104-4110.
64. Yaffe, D., and O. Saxel. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature (London) 270: 725-727.
65. Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fesquet, B. Henglein, and C. Bréchot. 1992. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182:1144-1154.